Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 PathwaysShiri Klein, Michal Abraham, Baruch Bulvik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal modelIdo D Weiss, Ezra Ella, Omri Dominsky, et al.The Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Matrix metalloproteinase 12 promotes tumor propagation in the lungEzra Ella, Yaniv Harel, Michal Abraham, et al.Bone Marrow Transplantation|May 21, 2020
Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performanceHilit Levy-Barazany, Liat Shachnai-Pinkas, Galina Rodionov, et al.Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.Pageof 4